Published in Science on November 25, 1994
Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells. J Virol (1996) 1.89
Regulatable gene expression systems for gene therapy applications: progress and future challenges. Mol Ther (2005) 1.61
Transduction profiles of recombinant adeno-associated virus vectors derived from serotypes 2 and 5 in the nigrostriatal system of rats. J Virol (2004) 1.45
Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats. Proc Natl Acad Sci U S A (1997) 1.26
Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease. Brain Res (2005) 1.15
Glucose modulates rat substantia nigra GABA release in vivo via ATP-sensitive potassium channels. J Clin Invest (1995) 1.13
Correction of a rat model of Parkinson's disease by coexpression of tyrosine hydroxylase and aromatic amino acid decarboxylase from a helper virus-free herpes simplex virus type 1 vector. Hum Gene Ther (2003) 1.10
Nonviral approaches for neuronal delivery of nucleic acids. Pharm Res (2007) 1.07
Long-term expression in sensory neurons in tissue culture from herpes simplex virus type 1 (HSV-1) promoters in an HSV-1-derived vector. J Virol (1995) 1.05
Reversal of motor impairments in parkinsonian rats by continuous intrastriatal delivery of L-dopa using rAAV-mediated gene transfer. Proc Natl Acad Sci U S A (2002) 1.04
Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirus-mediated gene transfer to a rat model of Parkinson's disease. Proc Natl Acad Sci U S A (1999) 0.98
A synopsis on the role of tyrosine hydroxylase in Parkinson's disease. CNS Neurol Disord Drug Targets (2012) 0.93
Herpes simplex virus type 1/adeno-associated virus rep(+) hybrid amplicon vector improves the stability of transgene expression in human cells by site-specific integration. J Virol (2002) 0.93
Regulatable gene expression systems for gene therapy. Curr Gene Ther (2006) 0.92
Future of cell and gene therapies for Parkinson's disease. Ann Neurol (2008) 0.92
Sparing of neuronal function postseizure with gene therapy. Proc Natl Acad Sci U S A (2000) 0.89
HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applications. Neoplasia (1999) 0.88
Regulatable promoters and gene therapy for Parkinson's disease: is the only thing to fear, fear itself? Exp Neurol (2007) 0.88
The effect of lentivirus-mediated TH and GDNF genetic engineering mesenchymal stem cells on Parkinson's disease rat model. Neurol Sci (2010) 0.85
Cationic amino acid based lipids as effective nonviral gene delivery vectors for primary cultured neurons. ACS Chem Neurosci (2013) 0.83
Behavioral effects and gene delivery in a rat model of Parkinson's disease. Science (1995) 0.82
Gene transfer of constitutively active protein kinase C into striatal neurons accelerates onset of levodopa-induced motor response alterations in parkinsonian rats. Brain Res (2003) 0.81
Versatile somatic gene transfer for modeling neurodegenerative diseases. Neurotox Res (2009) 0.80
Herpes simplex virus-based vectors. Int J Exp Pathol (2004) 0.80
Advances in gene therapy for movement disorders. Neurotherapeutics (2008) 0.79
Gene therapy for the treatment of Parkinson's disease: the nature of the biologics expands the future indications. Pharmaceuticals (Basel) (2012) 0.77
Human gene therapy and imaging in neurological diseases. Eur J Nucl Med Mol Imaging (2005) 0.77
Constitutive and Inducible Innate Responses in Cells Infected by HSV-1-Derived Amplicon Vectors. Open Virol J (2010) 0.75
Herpes simplex virus vectors for gene therapy in Parkinson's disease and other diseases of the nervous system. J R Soc Med (1999) 0.75
Neurovirological methods and their applications. J Neurol Neurosurg Psychiatry (2003) 0.75
Uptake of DNA by cancer cells without a transfection reagent. Biol Res (2017) 0.75
Subthalamic hGAD65 gene therapy and striatum TH gene transfer in a Parkinson's disease rat model. Neural Plast (2013) 0.75
A 16 bp upstream sequence from the rat tyrosine hydroxylase promoter supports long-term expression from a neurofilament promoter, in a helper virus-free HSV-1 vector system. Brain Res (2011) 0.75
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science (1987) 11.14
Complete DNA sequence of the short repeat region in the genome of herpes simplex virus type 1. Nucleic Acids Res (1986) 4.55
The nucleotide sequence of a rat 18 S ribosomal ribonucleic acid gene and a proposal for the secondary structure of 18 S ribosomal ribonucleic acid. J Biol Chem (1984) 4.00
Treatment of parkinsonism with levodopa. Arch Neurol (1969) 3.76
The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience (1989) 3.57
Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science (1990) 3.31
Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. N Engl J Med (1992) 3.23
First-strand cDNA synthesis primed with oligo(dT). Methods Enzymol (1987) 3.06
Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med (1992) 2.39
A defective HSV-1 vector expresses Escherichia coli beta-galactosidase in cultured peripheral neurons. Science (1988) 2.02
A single human gene encoding multiple tyrosine hydroxylases with different predicted functional characteristics. Nature (1987) 1.91
Retracted Long-term correction of rat model of Parkinson's disease by gene therapy. Nature (1993) 1.83
Latency competence of thirteen HSV-1 temperature-sensitive mutants. J Gen Virol (1980) 1.75
A protein tyrosine phosphatase expressed within dopaminoceptive neurons of the basal ganglia and related structures. J Neurosci (1993) 1.67
A latent, nonpathogenic HSV-1-derived vector stably expresses beta-galactosidase in mouse neurons. Neuron (1990) 1.57
Morphology and synaptic connections of crossed corticostriatal neurons in the rat. J Comp Neurol (1987) 1.52
Isolation and characterization of the human tyrosine hydroxylase gene: identification of 5' alternative splice sites responsible for multiple mRNAs. Biochemistry (1987) 1.45
Differential activation of hybrid genes containing herpes simplex virus immediate-early or delayed-early promoters after superinfection of stable DNA-transfected cell lines. J Virol (1985) 1.29
An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology. Proc Natl Acad Sci U S A (1990) 1.23
Expression of nerve growth factor in vivo from a defective herpes simplex virus 1 vector prevents effects of axotomy on sympathetic ganglia. Proc Natl Acad Sci U S A (1992) 1.21
Infection of cultured central nervous system neurons with a defective herpes simplex virus 1 vector results in stable expression of Escherichia coli beta-galactosidase. Proc Natl Acad Sci U S A (1990) 1.15
Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease. Proc Natl Acad Sci U S A (1989) 1.11
Clearance of exogenous dopamine in rat dorsal striatum and nucleus accumbens: role of metabolism and effects of locally applied uptake inhibitors. J Neurochem (1993) 1.08
Genetically modified cells: applications for intracerebral grafting. Trends Neurosci (1991) 1.06
Fetal neuronal grafts in monkeys given methylphenyltetrahydropyridine. Lancet (1986) 1.06
The organization and collateralization of corticostriate neurones in the motor and sensory cortex of the rat brain. Brain Res (1987) 1.05
Primate neostriatal neurons containing tyrosine hydroxylase: immunohistochemical evidence. Neurosci Lett (1987) 1.02
Developmental potential of quail dorsal root ganglion cells analyzed in vitro and in vivo. J Neurosci (1986) 1.00
Restoration of dopaminergic function by grafting of fetal rat substantia nigra to the caudate nucleus: long-term behavioral, biochemical, and histochemical studies. Ann Neurol (1980) 0.98
Tyrosine hydroxylase-like immunoreactive neurons in the striatum of the rat. Neurosci Lett (1989) 0.98
Striatal neurons with aromatic L-amino acid decarboxylase-like immunoreactivity in the rat. Neurosci Lett (1989) 0.96
Analysis of tyrosine hydroxylase and insulin transcripts in human neuroendocrine tissues. Brain Res Mol Brain Res (1990) 0.96
In vivo release of dopa and dopamine from genetically engineered cells grafted to the denervated rat striatum. Neuron (1990) 0.96
Four isoforms of tyrosine hydroxylase are expressed in human brain. Neuroscience (1993) 0.94
Gene expression of aromatic L-amino acid decarboxylase in cultured rat glial cells. J Neurochem (1992) 0.94
Tyrosine hydroxylase-immunoreactive intrinsic neurons in the rat cerebral cortex. Exp Brain Res (1987) 0.90
Dopamine cell replacement: Parkinson's disease. Annu Rev Neurosci (1990) 0.90
Clearance and diffusion of locally applied dopamine in normal and 6-hydroxydopamine-lesioned rat striatum. J Pharmacol Exp Ther (1992) 0.88
The use of a retroviral vector to identify foetal striatal neurones transplanted into the adult striatum. Exp Brain Res (1990) 0.87
Intrastriatal implantation of interleukin-1. Reduction of parkinsonism in rats by enhancing neuronal sprouting from residual dopaminergic neurons in the ventral tegmental area of the midbrain. J Neurosurg (1994) 0.87
Volume transmission of dopamine over large distances may contribute to recovery from experimental parkinsonism. Brain Res (1994) 0.86
An HSV-1 vector expressing tyrosine hydroxylase causes production and release of L-dopa from cultured rat striatal cells. J Neurochem (1995) 0.84
Demonstration of a pallidostriatal pathway by retrograde transport of HRP-labeled lectin. Brain Res (1981) 0.82
The immunocytochemical detection of herpes simplex virus in cervical smears--a valuable technique for routine use. J Pathol (1984) 0.81
Biochemical and behavioral correction of MPTP Parkinson-like syndrome by fetal cell transplantation. Ann N Y Acad Sci (1987) 0.81
Fetal dopamine neural grafts: extended reversal of methylphenyltetrahydropyridine-induced parkinsonism in monkeys. Prog Brain Res (1988) 0.81
Infection of cultured striatal neurons with a defective HSV-1 vector: implications for gene therapy. Nucleic Acids Res (1991) 0.80
Use of microdialysis for monitoring tyrosine hydroxylase activity in the brain of conscious rats. J Neurochem (1990) 0.79
Microdialysis monitoring of 3,4-dihydroxyphenylalanine accumulation after decarboxylase inhibition: a means to estimate in vivo changes in tyrosine hydroxylase activity of the rat locus ceruleus. J Neurochem (1993) 0.78
Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet (1994) 5.49
Alcoholism and alleles of the human D2 dopamine receptor locus. Studies of association and linkage. Arch Gen Psychiatry (1991) 4.12
Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain. Lancet (1993) 3.27
Metabotropic glutamate receptor 5 is a disulfide-linked dimer. J Biol Chem (1996) 2.17
A UGA termination suppression tRNATrp active in rabbit reticulocytes. Nature (1980) 2.10
Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells. J Virol (1996) 1.89
Cellular and molecular characterization of a brain-enriched protein tyrosine phosphatase. J Neurosci (1995) 1.79
A protein tyrosine phosphatase expressed within dopaminoceptive neurons of the basal ganglia and related structures. J Neurosci (1993) 1.67
Analysis of the structure and expression of the human dopamine D2A receptor gene. J Neurochem (1991) 1.64
The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity. J Biol Chem (2000) 1.60
Regulated release and polarized localization of brain-derived neurotrophic factor in hippocampal neurons. Mol Cell Neurosci (1996) 1.59
Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons. J Neurosci (1999) 1.58
Photoreceptors of mouse retinas possess D4 receptors coupled to adenylate cyclase. Proc Natl Acad Sci U S A (1992) 1.35
Two distinct mechanisms are involved in 6-hydroxydopamine- and MPP+-induced dopaminergic neuronal cell death: role of caspases, ROS, and JNK. J Neurosci Res (1999) 1.35
Generation of high-titer defective HSV-1 vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells. Biotechniques (1996) 1.28
Expression of nerve growth factor in vivo from a defective herpes simplex virus 1 vector prevents effects of axotomy on sympathetic ganglia. Proc Natl Acad Sci U S A (1992) 1.21
In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector. Gene Ther (1998) 1.16
A method to codetect introduced genes and their products in gene therapy protocols. Nat Biotechnol (1996) 1.16
STEP61: a member of a family of brain-enriched PTPs is localized to the endoplasmic reticulum. J Neurosci (1996) 1.13
A tyrosine hydroxylase-neurofilament chimeric promoter enhances long-term expression in rat forebrain neurons from helper virus-free HSV-1 vectors. Brain Res Mol Brain Res (2000) 1.12
Developmental cell death in dopaminergic neurons of the substantia nigra of mice. J Comp Neurol (2000) 1.12
Covalent and noncovalent interactions mediate metabotropic glutamate receptor mGlu5 dimerization. Mol Pharmacol (2001) 1.12
Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease. Proc Natl Acad Sci U S A (1989) 1.11
Genetic manipulation of STEP reverses behavioral abnormalities in a fragile X syndrome mouse model. Genes Brain Behav (2012) 1.08
Effect of pre- and postmortem variables on specific mRNA levels in human brain. Brain Res Mol Brain Res (1991) 1.07
Gene transfer into the nervous system. Mol Neurobiol (1987) 1.07
An HSV-1 vector containing the rat tyrosine hydroxylase promoter enhances both long-term and cell type-specific expression in the midbrain. J Neurochem (1997) 1.07
Inhibition of dopamine synthesis by dopamine D2 and D3 but not D4 receptors. J Pharmacol Exp Ther (1996) 1.06
Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblast and dopaminergic cell lines. J Pharmacol Exp Ther (1994) 1.05
Long-term expression in sensory neurons in tissue culture from herpes simplex virus type 1 (HSV-1) promoters in an HSV-1-derived vector. J Virol (1995) 1.05
Organization and evolution of the rat tyrosine hydroxylase gene. Biochemistry (1987) 1.04
Role of DNA-dependent protein kinase in neuronal survival. J Neurochem (2001) 1.04
A response element for the homeodomain transcription factor Ptx3 in the tyrosine hydroxylase gene promoter. J Neurochem (2000) 1.04
Diverse stabilities of expression in the rat brain from different cellular promoters in a helper virus-free herpes simplex virus type 1 vector system. Hum Gene Ther (1999) 1.04
HSV-1 vector-mediated gene transfer of the human nerve growth factor receptor p75hNGFR defines high-affinity NGF binding. J Neurosci (1993) 1.04
Enhanced early developmental expression of the metabotropic glutamate receptor mGluR5 in rat brain: protein, mRNA splice variants, and regional distribution. J Comp Neurol (1996) 1.04
The postnatal development of monocular optokinetic nystagmus in infants. Vision Res (1982) 1.03
Enhanced reporter gene expression in the rat brain from helper virus-free HSV-1 vectors packaged in the presence of specific mutated HSV-1 proteins that affect the virion. Brain Res Mol Brain Res (2001) 1.03
Molecular markers of neuronal subpopulations in layers 4, 5, and 6 of cat primary visual cortex. J Neurosci (1987) 1.00
Dopamine D2 and D3 receptors inhibit dopamine release. J Pharmacol Exp Ther (1994) 0.98
Expression of rat tyrosine hydroxylase in insect tissue culture cells and purification and characterization of the cloned enzyme. J Biol Chem (1990) 0.97
Modulation of rat rotational behavior by direct gene transfer of constitutively active protein kinase C into nigrostriatal neurons. J Neurosci (1998) 0.96
Analysis of tyrosine hydroxylase and insulin transcripts in human neuroendocrine tissues. Brain Res Mol Brain Res (1990) 0.96
Regulation of dopamine production by genetically modified primary fibroblasts. J Neurosci (1993) 0.95
Elevated DNA double strand breaks and apoptosis in the CNS of scid mutant mice. Cell Death Differ (2001) 0.95
Species and regional differences in the expression of cell-type specific elements at the human and rat tyrosine hydroxylase gene loci. J Neurochem (1990) 0.94
Fifty-one kilobase HSV-1 plasmid vector can be packaged using a helper virus-free system and supports expression in the rat brain. Biotechniques (2000) 0.92
Receptors specific for the carboxyl-terminal region of parathyroid hormone on bone-derived cells: determinants of ligand binding and bioactivity. Endocrinology (2004) 0.91
Identification of cell type-specific promoter elements associated with the rat tyrosine hydroxylase gene using transgenic founder analysis. Brain Res Mol Brain Res (1997) 0.91
General strategy for constructing large HSV-1 plasmid vectors that co-express multiple genes. Biotechniques (2001) 0.90
Characterization of MPP(+)-induced cell death in a dopaminergic neuronal cell line: role of macromolecule synthesis, cytosolic calcium, caspase, and Bcl-2-related proteins. Exp Neurol (1999) 0.89
L-Dopa and dopamine-producing gene cassettes for gene therapy approaches to Parkinson's disease. Exp Neurol (1997) 0.88
Dynamic changes in striatal dopamine D2 and D3 receptor protein and mRNA in response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) denervation in baboons. J Neurosci (1996) 0.88
HSV-1 vector mediated neuronal gene delivery. Strategies for molecular neuroscience and neurology. Biochem Pharmacol (1990) 0.87
An efficient in vivo recombination cloning procedure for modifying and combining HSV-1 cosmids. J Virol Methods (1999) 0.87
Activation of microglia during developmentally regulated cell death in the cerebral cortex. Dev Neurosci (1999) 0.87
Immortalized murine striatal neuronal cell lines expressing dopamine receptors and cholinergic properties. J Neurosci (1995) 0.86
A new TaqI RFLP within intron 2 of human dopamine D2 receptor gene (DRD2). Nucleic Acids Res (1991) 0.85
Immunoglobulin molecules are present in early-generated neuronal populations in the rat cerebral cortex and retina. J Comp Neurol (1997) 0.85
Morphogenic potentials of D2, D3, and D4 dopamine receptors revealed in transfected neuronal cell lines. Proc Natl Acad Sci U S A (1994) 0.84
kappa-Opioid tolerance and dependence in cultures of dopaminergic midbrain neurons. J Neurosci (1999) 0.84
Enhanced auditory reversal learning by genetic activation of protein kinase C in small groups of rat hippocampal neurons. Brain Res Mol Brain Res (2001) 0.84
Characterization of the human dopamine D3 receptor expressed in transfected cell lines. Eur J Pharmacol (1994) 0.84
Long-term persistence of defective HSV-1 vectors in the rat brain is demonstrated by reactivation of vector gene expression. Gene Ther (1996) 0.84
Helper virus-free HSV-1 vectors packaged both in the presence of VSV G protein and in the absence of HSV-1 glycoprotein B support gene transfer into neurons in the rat striatum. J Neurovirol (2001) 0.83
The mouse dopamine D2A receptor gene: sequence homology with the rat and human genes and expression of alternative transcripts. J Neurochem (1991) 0.83
Genes for catecholamine biosynthesis: cloning by expression and identification of the cDNA for rat dopamine beta-hydroxylase. Proc Natl Acad Sci U S A (1983) 0.83
Overexpression of Bcl-2 in a murine dopaminergic neuronal cell line leads to neurite outgrowth. Neurosci Lett (1996) 0.83
Overexpression of Bcl-2 attenuates MPP+, but not 6-ODHA, induced cell death in a dopaminergic neuronal cell line. Neurobiol Dis (1995) 0.82
Characterization of rat and human tyrosine hydroxylase genes: functional expression of both promoters in neuronal and non-neuronal cell types. Biochem Biophys Res Commun (1988) 0.82
Sequential cleavage of poly(ADP-ribose)polymerase and appearance of a small Bax-immunoreactive protein are blocked by Bcl-X(L) and caspase inhibitors during staurosporine-induced dopaminergic neuronal apoptosis. J Neurochem (1999) 0.82
Transfer of the nerve growth factor gene into cell lines and cultured neurons using a defective herpes simplex virus vector. Transfer of the NGF gene into cells by a HSV-1 vector. Brain Res Mol Brain Res (1994) 0.82
Transient compartmental expression of a family of protein tyrosine phosphatases in the developing striatum. Brain Res Dev Brain Res (1996) 0.82
IL-6 increases choline acetyltransferase but not neuropeptide transcripts in sympathetic neurons. Neuroreport (1994) 0.82
Expression of the E. coli Lac Z gene from a defective HSV-1 vector in various human normal, cancer-prone and tumor cells. FEBS Lett (1989) 0.81
Dopamine D2L receptor couples to G alpha i2 and G alpha i3 but not G alpha i1, leading to the inhibition of adenylate cyclase in transfected cell lines. J Pharmacol Exp Ther (1996) 0.80
L-3,4-dihydroxyphenylalanine synthesis by genetically modified Schwann cells. J Neurochem (1991) 0.80
Role of mitochondrial dysfunction and dopamine-dependent oxidative stress in amphetamine-induced toxicity. Ann Neurol (2001) 0.80
Differential expression of dopaminergic D2 receptor messenger RNAs during development. Brain Res Dev Brain Res (1991) 0.80
Expression of human tyrosine hydroxylase cDNA in invertebrate cells using a baculovirus vector. J Biol Chem (1988) 0.79
Cloning of ligand-specific cell lines via gene transfer: identification of a D2 dopamine receptor subtype. Proc Natl Acad Sci U S A (1989) 0.79
Population frequencies of tyrosine hydroxylase restriction fragment length polymorphisms in bipolar affective disorder. Biol Psychiatry (1989) 0.79
Molecular determinants of GABAergic local-circuit neurons in the visual cortex. Trends Neurosci (1989) 0.79
Developmental regulation of metabotropic glutamate receptor 5b protein in rodent brain. Neuroscience (2002) 0.78
Regions outside of the Bcl-2 homology domains, BH1 and BH2 protect a dopaminergic neuronal cell line from staurosporine-induced cell death. Brain Res Mol Brain Res (1997) 0.78
Use of defective herpes-derived plasmid vectors. Methods Mol Biol (1997) 0.77
Bax accelerates staurosporine-induced but suppresses nigericin-induced neuronal cell death. Neuroreport (1997) 0.77
The 3' flanking region of the human tyrosine hydroxylase gene directs reporter gene expression in peripheral neuroendocrine tissues. J Neurochem (1995) 0.77
Transient immunoglobulin-like molecules are present in the subplate zone and cerebral cortex during postnatal development. Cereb Cortex (1996) 0.77
Effect of exogenous nerve growth factor on neurotoxicity of and neuronal gene delivery by a herpes simplex amplicon vector in the rat brain. Hum Gene Ther (1994) 0.77
PTX-sensitive regulation of neurite outgrowth by the dopamine D3 receptor. Neuroreport (1996) 0.77
Molecular analysis of the function of the neuronal growth-associated protein GAP-43 by genetic intervention. Mol Neurobiol (1991) 0.77
The rat D4 dopamine receptor couples to cone transducin (Galphat2) to inhibit forskolin-stimulated cAMP accumulation. J Biol Chem (1997) 0.77
Genetic analysis of neuronal physiology with defective herpes simplex virus vectors. Adv Neurol (1999) 0.77
The dopamine receptor DRD4 gene: are duplications distracting? Trends Pharmacol Sci (2001) 0.76
Neuronal subsets express multiple high-molecular-weight cell-surface glycoconjugates defined by monoclonal antibodies Cat-301 and VC1.1. J Neurosci (1990) 0.76